慢性粒单核细胞白血病：2015年该领域的前沿
Chronic myelomonocytic leukemia: Forefront of the field in 2015.
作者信息
Benton Christopher B, Nazha Aziz, Pemmaraju Naveen, Garcia-Manero Guillermo
机构信息
Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
出版信息
Crit Rev Oncol Hematol. 2015 Aug;95(2):222-42. doi: 10.1016/j.critrevonc.2015.03.002. Epub 2015 Mar 14.
Abstract
Chronic myelomonocytic leukemia (CMML) includes components of both myelodysplastic syndrome and myeloproliferative neoplasms and is associated with a characteristic peripheral monocytosis. CMML is caused by the proliferation of an abnormal hematopoietic stem cell clone and may be influenced by microenvironmental changes. The disease is rare and has undergone revisions in its classification. We review the recent classification strategies as well as diagnostic criteria, focusing on CMML's genetic alterations and unique pathophysiology. We also discuss the latest molecular characterization of the disease, including how molecular factors affect current prognostic models. Finally, we focus on available treatment strategies, with a special emphasis on experimental and forthcoming therapies.
摘要
慢性粒单核细胞白血病（CMML）兼具骨髓增生异常综合征和骨髓增殖性肿瘤的成分，并伴有特征性的外周血单核细胞增多。CMML 由异常造血干细胞克隆增殖引起，可能受微环境变化影响。该疾病较为罕见，其分类已历经修订。我们回顾了近期的分类策略以及诊断标准，重点关注 CMML 的基因改变和独特的病理生理学。我们还讨论了该疾病的最新分子特征，包括分子因素如何影响当前的预后模型。最后，我们重点关注可用的治疗策略，特别强调实验性和即将出现的疗法。
相似文献
1
Chronic myelomonocytic leukemia: Forefront of the field in 2015.慢性粒单核细胞白血病：2015年该领域的前沿
Crit Rev Oncol Hematol. 2015 Aug;95(2):222-42. doi: 10.1016/j.critrevonc.2015.03.002. Epub 2015 Mar 14.
2
Chronic myelomoncytic leukemia: Are we finally solving the identity crisis?慢性粒单核细胞白血病：我们终于要解决其身份危机了吗？
Blood Rev. 2016 Sep;30(5):381-8. doi: 10.1016/j.blre.2016.04.006. Epub 2016 Apr 25.
3
Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome?慢性粒单核细胞白血病（CMML）——一种骨髓增生异常综合征还是骨髓增殖性综合征？
Leuk Lymphoma. 1993 Jan;9(1-2):35-41. doi: 10.3109/10428199309148501.
4
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML.骨髓增生异常综合征/骨髓增殖性肿瘤重叠综合征患者来源的强大异种移植模型体现了慢性粒单核细胞白血病和青少年型骨髓单核细胞白血病的独特特征。
Blood. 2017 Jul 27;130(4):397-407. doi: 10.1182/blood-2017-01-763219. Epub 2017 Jun 2.
5
Prognostic significance of monocytosis in patients with myeloproliferative disorders.骨髓增殖性疾病患者单核细胞增多的预后意义
Leuk Lymphoma. 2006 Mar;47(3):417-23. doi: 10.1080/10428190500305448.
6
Myelodysplastic/myeloproliferative neoplasms.骨髓增生异常/骨髓增殖性肿瘤。
Hematology Am Soc Hematol Educ Program. 2011;2011:264-72. doi: 10.1182/asheducation-2011.1.264.
7
Therapy for Chronic Myelomonocytic Leukemia in a New Era.新时代慢性粒单核细胞白血病的治疗
Curr Hematol Malig Rep. 2017 Oct;12(5):468-477. doi: 10.1007/s11899-017-0408-8.
8
Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms.靶向慢性髓性白血病和费城染色体阴性经典骨髓增殖性肿瘤中的异常造血干细胞
Int J Mol Sci. 2021 Jan 11;22(2):659. doi: 10.3390/ijms22020659.
9
Chronic myelomonocytic leukemia: myelodysplastic or myeloproliferative?慢性粒单核细胞白血病：骨髓增生异常还是骨髓增殖性？
Best Pract Res Clin Haematol. 2013 Dec;26(4):387-400. doi: 10.1016/j.beha.2013.09.006. Epub 2013 Oct 1.
10
What is the role of the microenvironment in MDS?微环境在 MDS 中扮演什么角色？
Best Pract Res Clin Haematol. 2019 Dec;32(4):101113. doi: 10.1016/j.beha.2019.101113. Epub 2019 Oct 28.
引用本文的文献
1
Myeloid leukemoid reaction after initial azacitidine therapy for chronic myelomonocytic leukemia.慢性粒单核细胞白血病初次使用阿扎胞苷治疗后的髓样类白血病反应。
Int J Hematol. 2022 Dec;116(6):961-965. doi: 10.1007/s12185-022-03422-9. Epub 2022 Jul 19.
2
Kidney Involvement in Patients With Chronic Myelomonocytic Leukemia or BCR-ABL-Negative Myeloproliferative Neoplasms.慢性粒单核细胞白血病或BCR-ABL阴性骨髓增殖性肿瘤患者的肾脏受累情况
Kidney Int Rep. 2020 Dec 14;6(3):737-745. doi: 10.1016/j.ekir.2020.12.005. eCollection 2021 Mar.
3
Chronic Myelomonocytic Leukemia Presenting With Polyserositis and Seropositivity for Rheumatoid Arthritis.慢性髓单核细胞白血病伴多发性浆膜炎和类风湿关节炎血清阳性。
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620966863. doi: 10.1177/2324709620966863.
4
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions.经典慢性髓单核细胞白血病（CMML）、CMML 变异型和 CMML 前期疾病的拟议诊断标准。
Haematologica. 2019 Oct;104(10):1935-1949. doi: 10.3324/haematol.2019.222059. Epub 2019 May 2.
5
Alteration in the Cytokine Secretion of Bone Marrow Stromal Cells from Patients with Chronic Myelomonocytic Leukemia Contribute to Impaired Hematopoietic Supportive Activity.慢性粒单核细胞白血病患者骨髓基质细胞细胞因子分泌的改变导致造血支持活性受损。
Stem Cells Int. 2018 Jul 10;2018:5921392. doi: 10.1155/2018/5921392. eCollection 2018.
6
Outcome of patient with high-risk chronic myelomonocytic leukemia, treated with decitabine prior to transformation to acute myeloid leukemia: A case report.高危慢性粒单核细胞白血病患者在转化为急性髓系白血病之前接受地西他滨治疗的结果：一例报告
Oncol Lett. 2018 May;15(5):7132-7138. doi: 10.3892/ol.2018.8236. Epub 2018 Mar 12.
7
Routine blood examinations combined with morphological analysis for the diagnosis of myelodysplastic/myeloproliferative neoplasms.常规血液检查联合形态学分析用于诊断骨髓增生异常/骨髓增殖性肿瘤。
Oncol Lett. 2016 Nov;12(5):4245-4251. doi: 10.3892/ol.2016.5165. Epub 2016 Sep 21.
8
Transformation of Canine Lymphoma/Leukemia to More Aggressive Diseases: Anecdotes or Reality?犬淋巴瘤/白血病向更具侵袭性疾病的转化：传闻还是现实？
Front Vet Sci. 2015 Oct 7;2:42. doi: 10.3389/fvets.2015.00042. eCollection 2015.
本文引用的文献
1
Phase I study of S-trans, trans-farnesylthiosalicylic acid (salirasib), a novel oral RAS inhibitor in patients with refractory hematologic malignancies.新型口服RAS抑制剂S-反式，反式-法尼基硫代水杨酸（salirasib）用于难治性血液系统恶性肿瘤患者的I期研究。
Clin Lymphoma Myeloma Leuk. 2015 Jul;15(7):433-438.e2. doi: 10.1016/j.clml.2015.02.018. Epub 2015 Feb 19.
2
Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias.基于原始髓细胞和白细胞计数的慢性粒单核细胞白血病精细分类
Leuk Res. 2014 Dec;38(12):1413-9. doi: 10.1016/j.leukres.2014.09.003. Epub 2014 Sep 17.
3
Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study.慢性粒单核细胞白血病细胞遗传学异常的分子和预后相关性：一项 Mayo 诊所-法国联合会研究。
Am J Hematol. 2014 Dec;89(12):1111-5. doi: 10.1002/ajh.23846. Epub 2014 Sep 26.
4
Monosomal karyotype predicts adverse prognosis in patients diagnosed with chronic myelomonocytic leukemia: a single-institution experience.单体核型预测慢性粒单核细胞白血病患者的不良预后：单机构经验
Clin Lymphoma Myeloma Leuk. 2015 Feb;15(2):e39-41. doi: 10.1016/j.clml.2014.06.007. Epub 2014 Jun 10.
5
Lenalidomide and metronomic melphalan for CMML and higher risk MDS: a phase 2 clinical study with biomarkers of angiogenesis.来那度胺和节拍性美法仑治疗 CMML 和高危 MDS：伴有血管生成生物标志物的 2 期临床研究。
Leuk Res. 2014 Jul;38(7):756-63. doi: 10.1016/j.leukres.2014.03.022. Epub 2014 Apr 5.
6
Combined MEK and JAK inhibition abrogates murine myeloproliferative neoplasm.MEK 和 JAK 联合抑制消除了小鼠骨髓增生性肿瘤。
J Clin Invest. 2014 Jun;124(6):2762-73. doi: 10.1172/JCI74182. Epub 2014 May 8.
7
Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution.来自单一机构的417例慢性粒单核细胞白血病患者的细胞遗传学风险分层
Am J Hematol. 2014 Aug;89(8):813-8. doi: 10.1002/ajh.23751. Epub 2014 May 16.
8
Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review.慢性粒单核细胞白血病：简明临床与病理生理学综述。
Br J Haematol. 2014 May;165(3):273-86. doi: 10.1111/bjh.12756. Epub 2014 Jan 28.
9
Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents.低甲基化剂治疗可增强骨髓增生异常综合征中 PD-L1、PD-L2、PD-1 和 CTLA4 的表达。
Leukemia. 2014 Jun;28(6):1280-8. doi: 10.1038/leu.2013.355. Epub 2013 Nov 25.
10
Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice.Asxl1 缺失导致小鼠出现骨髓增生异常综合征样疾病。
Blood. 2014 Jan 23;123(4):541-53. doi: 10.1182/blood-2013-05-500272. Epub 2013 Nov 19.
Zotero 插件